Investors in OpenAI have begun questioning the startup’s sky‑high $852 billion valuation after the company announced a shift in product strategy, according to a report by the Financial Times. The scrutiny stems from concerns that recent changes could dilute the economic justification for the figure that underpins the firm’s latest funding round.

The valuation, derived from a mix of private‑equity stakes and projected AI revenue, has long been a benchmark for the sector. However, as OpenAI pivots toward enterprise‑grade tools and throttles consumer‑focused rollouts, limited data on monetisation pathways fuels investor unease. Analysts note that a lower‑than‑expected adoption curve could pressure future financing terms.

Board members and early backers are reportedly requesting more granular forecasts before committing additional capital, a move that could stall OpenAI’s aggressive hiring and research timetable. If the company fails to align its strategic roadmap with realistic revenue projections, the once‑celebrated valuation may be revised downward, forcing a recalibration of partnership deals across the AI ecosystem.

The pressure highlights a broader tension in the generative‑AI market, where hype‑driven valuations clash with the practical costs of scaling compute and safety infrastructure. Stakeholders now watch OpenAI’s next product release for signals on whether the firm can translate its research edge into sustainable cash flow, a test that will shape funding dynamics industry‑wide.